Extracellular Vesicles of the Probiotic Escherichia coli Nissle 1917 Reduce PepT1 Levels in IL-1ß-Treated Caco-2 Cells via Upregulation of miR-193a-3p
Por:
Olivo-Martínez Y, Martínez-Ruiz S, Cordero C, Badia-Palacin J and Baldoma L
Publicada:
1 ago 2024
Ahead of Print:
15 ago 2024
Resumen:
PepT1, a proton-coupled oligopeptide transporter, is crucial for intestinal homeostasis. It is mainly expressed in small intestine enterocytes, facilitating the absorption of di/tri-peptides from dietary proteins. In the colon, PepT1 expression is minimal to prevent excessive responses to proinflammatory peptides from the gut microbiota. However, increased colonic PepT1 is linked to chronic inflammatory diseases and colitis-associated cancer. Despite promising results from animal studies on the benefits of extracellular vesicles (EVs) from beneficial gut commensals in treating IBD, applying probiotic EVs as a postbiotic strategy in humans requires a thorough understanding of their mechanisms. Here, we investigate the potential of EVs of the probiotic Nissle 1917 (EcN) and the commensal EcoR12 in preventing altered PepT1 expression under inflammatory conditions, using an interleukin (IL)-1-induced inflammation model in Caco-2 cells. The effects are evaluated by analyzing the expression of PepT1 (mRNA and protein) and miR-193a-3p and miR-92b, which regulate, respectively, PepT1 mRNA translation and degradation. The influence of microbiota EVs on PepT1 expression is also analyzed in the presence of bacterial peptides that are natural substrates of colonic PepT1 to clarify how the regulatory mechanisms function under both physiological and pathological conditions. The main finding is that EcN EVs significantly decreases PepT1 protein via upregulation of miR-193a-3p. Importantly, this regulatory effect is strain-specific and only activates in cells exposed to IL-1 beta, suggesting that EcN EVs does not control PepT1 expression under basal conditions but can play a pivotal role in response to inflammation as a stressor. By this mechanism, EcN EVs may reduce inflammation in response to microbiota in chronic intestinal disorders by limiting the uptake of bacterial proinflammatory peptides.
Filiaciones:
Olivo-Martínez Y:
Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
Biochemistry and Diseases Research Group, Facultad de Medicina, Universidad de Cartagena, Cartagena 130015, Colombia
Institut de Biomedicina de la Universitat de Barcelona(IBUB), 08028 Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain
:
Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
Institut de Biomedicina de la Universitat de Barcelona(IBUB), 08028 Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain
Cordero C:
Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
Institut de Biomedicina de la Universitat de Barcelona(IBUB), 08028 Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain
Badia-Palacin J:
Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
Institut de Biomedicina de la Universitat de Barcelona(IBUB), 08028 Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain
Baldoma L:
Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028 Barcelona, Spain
Institut de Biomedicina de la Universitat de Barcelona(IBUB), 08028 Barcelona, Spain
Institut de Recerca Sant Joan de Déu (IRSJD), 08950 Barcelona, Spain
Green Submitted, gold
|